Trial Profile
Define in Preclinical Diastolic Dysfunction (PDD) With Renal Dysfunction, the Cardiorenal and Humoral Actions of Chronic Type V Phosphodiesterase (PDEV) Inhibition
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Kidney disorders; Left ventricular dysfunction
- Focus Pharmacodynamics
- Acronyms Aim3
- 15 Jan 2020 Status changed from recruiting to completed.
- 20 Mar 2019 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 20 Mar 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jun 2019.